z-logo
open-access-imgOpen Access
The clinical significance of CD97, NF-kB and COX-2 ingastric MALT lymphomas
Author(s) -
Shao-liang Han,
Jun Cheng,
Ximei Wu,
Zengrong Jia,
Pengfei Wang,
Zhanwei Wang
Publication year - 2011
Publication title -
journal of biomedical science and engineering
Language(s) - English
Resource type - Journals
eISSN - 1937-688X
pISSN - 1937-6871
DOI - 10.4236/jbise.2011.47061
Subject(s) - lymphoma , submucosa , stage (stratigraphy) , helicobacter pylori , clinical significance , malt lymphoma , gastroenterology , pathology , gastric mucosa , medicine , stomach , biology , paleontology
Background and Objectives: Increased expression of the CD97, nuclear factor-kB (NF-kB) and cyclooxygenase-2 (COX-2) has been found to play an important role in development of many cancers, including gastric neoplasm. However, the expression and biological behavior of CD97, NF-kB and COX-2 in gastric MALT (mucosa-associated lymphoid tissue) lymphoma has not been well investigated. Methods: The expressions of CD97, COX-2 and NF-kB in 47 cases of gastric MALT lymphoma were detected immunohistochemically, and the relevance between their expressions and the biological behavior was analyzed retrospectively. Results: 1) The expressions of CD97, NF-kB and COX-2 were 87.2%, 36.2% and 48.9%, respectively; 2) The difference of CD97 expression between depth of invasion limited in mucosa and submucosa and beyond muscularis propria was significant (100.0% vs. 71.4%, P < 0.01). Moreover, the expression of nuclear CD97 between stage IIE, III, IV and stage I patients showed significant difference (96.4% vs. 73.7%, P < 0.05); 3) The expression of NF-kB was significantly correlated with tumor size, depth of invasion and stage; 4) The expression of COX-2 was significantly correlated with Helicobacter pylori infection, clinical stage, depth of invasion and tumor size (P < 0.05). Conclusions: Expressions of CD97, NF-κB and COX-2 were correlated with tumor invasion and metastasis in gastric MALT lymphoma

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here